WILMINGTON, Del., April 15, 2020 /PRNewswire/ -- DuPont
(NYSE:DD) today launched a new program, #TyvekTogether, to
increase the overall availability of
Tyvek® personal protective garments in the
company's continued efforts to help combat the spread of COVID-19
and protect health care workers. At full capacity, this
initiative could deliver 6 million additional non-surgical
isolation gowns per month by enabling others to join us in
protecting even more frontline responders.
"There's a critical need for protective apparel, and we believe
that working with other companies to convert their existing
cut-and-sew manufacturing capacity to protective garment
fabrication is the fastest way to protect more people," said
John Richard, Vice President &
General Manager of DuPont Safety Solutions. "Our dedicated
employees around the world are working 24/7 to make more
Tyvek® material and patterns available to more
organizations, working together to protect those who are protecting
us."
DuPont has invested in equipment and technology to significantly
increase its production of Tyvek® and
Tychem® garments globally to meet the
ever-increasing demand for personal protection equipment
(PPE). Since January we have increased production of
Tyvek® garments by more than 9 million garments per
month specifically for COVID-19 response, which is more than double
the amount produced for any prior crisis. The
#TyvekTogether Program will introduce a new specialized
Tyvek® fabric to enable an increase in the
amount of garment production for the COVID-19 response to 15
million garments a month.
The #TyvekTogether Program includes the following
components:
- A new #TyvekTogether fabric,
Tyvek® style 1222A, that has similar barrier
properties to the core
DuPont™ Tyvek® 400 garment
offerings with adjusted fabric drape and hand to optimize material
usage.
- Tyvek® style 1222A is available in roll-good
form to existing and new customers with available cut-and-sew
capabilities to increase the total amount of
Tyvek® garments available as quickly as possible.
- DuPont will provide garment designs—including patterns and
virtual manufacturing support—for a non-surgical isolation
gown and a coverall that are optimized for simple and
productive manufacturing. With these patterns and technical
assistance, we aim to accelerate the speed that new converters are
able to begin producing PPE.
- Partners can also use their own designs for coveralls and
garments to meet local needs.
- Additionally, DuPont will donate more than 57,000
Tyvek® coveralls directly to the states in the
US most impacted by COVID-19.
The DuPont Personal Protection unit of DuPont Safety &
Construction remains committed to helping to protect those who
protect others, especially as we strive to protect the dedicated
workers on the front lines fighting COVID-19. For more
information about the #TyvekTogether program, visit
TyvekTogether.dupont.com.
For more information about DuPont's complete COVID-19 response
efforts, please visit,
https://www.dupont.com/news/dupont-response-novel-coronavirus-prevention-and-control.html
View Media Assets Here
About DuPont Personal Protection
From first responders to industrial workers, DuPont provides a wide
range of personal protection solutions including some of the most
trusted and innovative brands in the industry, such as
Kevlar®, Nomex®, Tyvek®, and
Tychem® to meet your safety needs. More information
can be found at www.personalprotection.dupont.com
About DuPont Safety & Construction
DuPont Safety & Construction is a global leader in delivering
innovation for life's essential needs in water, shelter and safety;
enabling its customers to win through unique capabilities, global
scale and iconic brands including Corian®,
Kevlar®, Nomex®, Tyvek®, GreatStuff™,
Styrofoam™ and Filmtec®.
About DuPont
DuPont (NYSE: DD) is a global innovation leader with
technology-based materials, ingredients and solutions that help
transform industries and everyday life. Our employees apply
diverse science and expertise to help customers advance their best
ideas and deliver essential innovations in key markets including
electronics, transportation, construction, water, health and
wellness, food, and worker safety. More information can be
found at www.dupont.com/.
Cautionary Statement Regarding Forward Looking
Statements
This communication contains "forward-looking statements"
within the meaning of the federal securities laws, including
Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended. In this
context, forward-looking statements often address expected future
business and financial performance and financial condition, and
often contain words such as "expect," "anticipate," "intend,"
"plan," "believe," "seek," "see," "will," "would," "target," and
similar expressions and variations or negatives of these
words.
On April 1, 2019, the company
completed the separation of its materials science business into a
separate and independent public company by way of a pro rata
dividend-in-kind of all the then outstanding stock of Dow
Inc. (the "Dow Distribution"). The company completed the
separation of its agriculture business into a separate and
independent public company on June 1,
2019, by way of a pro rata dividend-in-kind of all the then
outstanding stock of Corteva, Inc. (the "Corteva
Distribution").
On December 15, 2019, DuPont
and IFF announced they had entered definitive agreements to combine
DuPont's Nutrition & Biosciences business with IFF in a
transaction that would result in IFF issuing shares to DuPont
shareholders, pending customary closing conditions, other approvals
including regulatory and that of IFF's shareholders.
Forward-looking statements address matters that are, to
varying degrees, uncertain and subject to risks, uncertainties and
assumptions, many of which that are beyond DuPont's control, that
could cause actual results to differ materially from those
expressed in any forward-looking statements. Forward-looking
statements are not guarantees of future results. Some of the
important factors that could cause DuPont's actual results to
differ materially from those projected in any such forward-looking
statements include, but are not limited to: (i) the parties'
ability to meet expectations regarding the timing, completion and
accounting and tax treatments of the proposed transaction with IFF;
changes in relevant tax and other laws, (ii) failure to obtain
necessary regulatory approvals, approval of IFF's shareholders,
anticipated tax treatment or any required financing or to satisfy
any of the other conditions to the proposed transaction with IFF,
(iii) the possibility that unforeseen liabilities, future capital
expenditures, revenues, expenses, earnings, synergies, economic
performance, indebtedness, financial condition, losses, future
prospects, business and management strategies that could impact the
value, timing or pursuit of the proposed transaction with IFF, (iv)
risks and costs and pursuit and/or implementation of the separation
of the N&B Business, including timing anticipated to complete
the separation, any changes to the configuration of businesses
included in the separation if implemented, (v) risks and costs
related to the Dow Distribution and the Corteva Distribution
(together, the "Distributions") including (a) with respect to
achieving all expected benefits from the Distributions; (b) the
incurrence of significant costs in connection with the
Distributions, including costs to service debt incurred by the
Company to establish the relative credit profiles of Corteva, Dow
and DuPont and increased costs related to supply, service and other
arrangements that, prior to the Dow Distribution, were between
entities under the common control of DuPont; (c) indemnification of
certain legacy liabilities of E. I. du Pont de Nemours and Company
("Historical EID") in connection with the Corteva Distribution; and
(d) potential liability arising from fraudulent conveyance and
similar laws in connection with the Distributions; (vi) failure to
effectively manage acquisitions, divestitures, alliances, joint
ventures and other portfolio changes, including meeting conditions
under the Letter Agreement entered in connection with the Corteva
Distribution, related to the transfer of certain levels of assets
and businesses; (vii) uncertainty as to the long-term value of
DuPont common stock; (viii) potential inability or reduced access
to the capital markets or increased cost of borrowings, including
as a result of a credit rating downgrade and (ix) other risks to
DuPont's business, operations and results of operations including
from: failure to develop and market new products and optimally
manage product life cycles; ability, cost and impact on business
operations, including the supply chain, of responding to changes in
market acceptance, rules, regulations and policies and failure to
respond to such changes; outcome of significant litigation,
environmental matters and other commitments and contingencies;
failure to appropriately manage process safety and product
stewardship issues; global economic and capital market conditions,
including the continued availability of capital and financing, as
well as inflation, interest and currency exchange rates; changes in
political conditions, including tariffs, trade disputes and
retaliatory actions; impairment of goodwill or intangible assets;
the availability of and fluctuations in the cost of energy and raw
materials; business or supply disruption, including in connection
with the Distributions; ability to effectively manage costs as the
company's portfolio evolves; the unpredictability and inherent
uncertainty in duration and extent of events including
security threats, such as acts of sabotage, terrorism or war;
natural disasters and weather events and patterns; public health
issues, epidemics and pandemics, including the novel coronavirus
(COVID-19) and the responses thereto (such as voluntary and in some
cases, mandatory quarantines as well as shut downs and other
restrictions on travel and commercial, social and other activities)
which could or could continue to result in a significant
operational event for DuPont, adversely impact demand or
production; ability to discover, develop and protect new
technologies and to protect and enforce DuPont's intellectual
property rights; unpredictability and severity of catastrophic
events, including, but not limited to, acts of terrorism or
outbreak of war or hostilities, as well as management's response to
any of the aforementioned factors. These risks are and will be more
fully discussed in DuPont's current, quarterly and annual reports
and other filings made with the U.S. Securities and Exchange
Commission, in each case, as may be amended from time to time in
future filings with the SEC. While the list of factors presented
here is considered representative, no such list should be
considered a complete statement of all potential risks and
uncertainties. Unlisted factors may present significant additional
obstacles to the realization of forward-looking statements.
Consequences of material differences in results as compared with
those anticipated in the forward-looking statements could include,
among other things, business disruption, operational problems,
financial loss, legal liability to third parties and similar risks,
any of which could have a material adverse effect on DuPont's
consolidated financial condition, results of operations, credit
rating or liquidity. You should not place undue reliance on
forward-looking statements, which speak only as of the date they
are made. DuPont assumes no obligation to publicly provide
revisions or updates to any forward-looking statements whether as a
result of new information, future developments or otherwise, should
circumstances change, except as otherwise required by securities
and other applicable laws. A detailed discussion of some of the
significant risks and uncertainties which may cause results and
events to differ materially from such forward-looking statements is
included in the section titled "Risk Factors" (Part I, Item 1A) of
DuPont's 2019 Annual Report on Form 10-K as updated by DuPont's
subsequent periodic and current reports filed with the SEC.
DuPont™, the DuPont Oval Logo, and all trademarks and service
marks denoted with ™, ℠ or ® are owned by affiliates of DuPont
de Nemours, Inc. unless otherwise noted.
For further information contact:
Dan Turner
+1-302-299-7628
Daniel.A.Turner@dupont.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/dupont-launches-tyvektogether-increasing-protective-garment-supply-301041060.html
SOURCE DuPont